Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 63187-427

7 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 63187-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valhyctz Fig1)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valhyctz Fig1)
A line graph showing the probability of achieving systolic blood pressure under 140 mmHg at Week 8. The x-axis represents baseline systolic blood pressure (mmHg) from 140 to 180, and the y-axis shows the percentage achieving target blood pressure from 0% to 100%. Four lines compare treatment groups: Valsartan and Hydrochlorothiazide 320 mg/25 mg (highest probability), Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo (lowest probability).*
FDA Label Image

63187-427-90 (Valhyctz Fig11)

63187-427-90 (Valhyctz Fig11)
Label for Valsartan HCTZ 320 mg / 12.5 mg film-coated tablets, containing 90 tablets per container. The label includes dosage strength, description of tablet appearance (pink, oval, biconvex, debossed with '1' and '64'), manufacturer Aurobindo Pharma Limited, and relabeler Proficient Rx LP. NDC 63187-427-90 is displayed along with storage instructions and lot/expiration placeholders.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valhyctz Fig2)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valhyctz Fig2)
This chart displays the probability of achieving diastolic blood pressure (DBP) ≤90 mmHg as a percentage across baseline DBP values from 90 to 110 mmHg for several treatments: Valsartan and Hydrochlorothiazide 320 mg/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The graph shows higher probabilities with combination therapy compared to individual components and placebo.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valhyctz Fig3)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valhyctz Fig3)
A line graph depicting the probability of achieving systolic blood pressure (SBP) below 130 mmHg at week 8. The x-axis represents baseline SBP in mmHg (range 140 to 180), and the y-axis shows the percentage achieving SBP <130 mmHg (0 to 100%). Four treatments are compared: Valsartan and Hydrochlorothiazide 320 mg/25 mg (highest probability), Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo (lowest probability).*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Valhyctz Fig4)

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Valhyctz Fig4)
A line graph showing the probability of achieving diastolic blood pressure (DBP) less than 80 mmHg at week 8. The x-axis represents baseline DBP in mmHg from 90 to 110, and the y-axis shows the percentage achieving DBP <80 from 0 to 100%. The graph compares four groups: Valsartan and Hydrochlorothiazide 320 mg/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, illustrating higher effectiveness of the combination treatment.*
FDA Label Image

Valsartan Chemical Structure (Valhyctz Str1)

Valsartan Chemical Structure (Valhyctz Str1)
Chemical structure of Valsartan as shown in the image, illustrating the molecular formula with specific functional groups and stereochemistry details.*
FDA Label Image

Hydrochlorothiazide Chemical Structure (Valhyctz Str2)

Hydrochlorothiazide Chemical Structure (Valhyctz Str2)
Chemical structure diagram of the active ingredient Valsartan and Hydrochlorothiazide. The image shows the molecular configuration including functional groups like sulfonamide, chlorine substitution on a benzene ring, and other characteristic bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.